Back to Journals » OncoTargets and Therapy » Volume 16

Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date

Total article views   HTML views PDF downloads Totals
9,857 Dovepress* 4,663+ 127 4,790
PubMed Central* 5,194 556 5,750
Totals 9,857 683 10,540
*Since 23 March 2023
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 4 8

View citations on PubMed Central and Google Scholar